Exelixis Announces January 31 Webcast of Presentation at the 2008 Wachovia Healthcare Conference

... SOUTH SAN FRANCISCO Calif. Jan. 24 /-Exe...The presentation will be webcast and may be accessed in the EventCale...About Exelixis ...Exelixis Inc. is a development-stage biotechnology company dedicated...

The presentation will be webcast and may be accessed in the Event
Calendar page under Investors on the Exelixis website at
http://www.exelixis.com.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated
to the discovery and development of novel small molecule therapeutics for
the treatment of cancer and other serious diseases. The company is
leveraging its fully integrated drug discovery platform to fuel the growth
of its development pipeline, which is primarily focused on cancer.
Currently, Exelixis' broad product pipeline includes investigational
compounds in phase 2 and phase 1 clinical development. Exelixis has
established strategic corporate alliances with major pharmaceutical and
biotechnology companies, including GlaxoSmithKline, Bristol-Myers Squibb
Company, Genentech, Wyeth Pharmaceuticals and Daiichi-Sankyo. For more
information, please visit the company's web site at
http://www.exelixis.com.

(Date:12/9/2016)... December 9, 2016 The research ... five players in the Global Label-Free Array Systems Market ... market in 2015. Players such as Biacore, Agilent Technologies, ... dominant in the global market due to their unmatched ... innovation. Product upgrades and timely product launches are expected ...

(Date:11/21/2016)... , Nov. 21, 2016 Neurotechnology ... object recognition technologies, today announced that the MegaMatcher ... cards was submitted for the NIST Minutiae ... passed all the mandatory steps of the evaluation ... is a continuing test of fingerprint templates used ...